Nuveen’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,109,490
Closed -$742K 3535
2022
Q1
$742K Buy
1,109,490
+5,172
+0.5% +$3.98K ﹤0.01% 2909
2021
Q4
$1.22M Sell
1,104,318
-299,519
-21% -$463K ﹤0.01% 2788
2021
Q3
$2.78M Buy
1,403,837
+255,083
+22% +$573K ﹤0.01% 2521
2021
Q2
$3.64M Buy
+1,148,754
New +$2.87M ﹤0.01% 2405
2020
Q1
Sell
-68,554
Closed -$101K 3274
2019
Q4
$101K Sell
68,554
-50,450
-42% -$175K ﹤0.01% 3129
2019
Q3
$959K Sell
119,004
-1,792
-1% -$24.4K ﹤0.01% 2721
2019
Q2
$2.14M Buy
+120,796
New +$2.64M ﹤0.01% 2404

Other funds holding ASXC

Nuveen's ASXC Position: Q2 2022 in Review

Nuveen sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 1,109,490 shares — an estimated $742K sold.

Nuveen first reported a position in ASXC in Q2 2019 and held it in 7 quarters. The position peaked at $3.64M in Q2 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Nuveen reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 1,109,490 Asensus Surgical, Inc. shares in Q2 2022, an estimated $742K.
  • Nuveen first reported a position in Asensus Surgical, Inc. in Q2 2019 and held it in 7 quarters.
  • Nuveen's Asensus Surgical, Inc. position peaked at $3.64M in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.